Argus
•
Apr 30, 2026
Thermo Fisher Scientific Inc.: Redeploying capital to drive growth
Summary
Thermo Fisher manufactures scientific instruments, consumables, and chemicals. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma services. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Illumina, Inc.
May 01, 2026
•
ILMN
Analyst Report: Stryker Corporation
May 01, 2026
•
SYK
Analyst Report: Bio-Rad Laboratories, Inc.
May 01, 2026
•
BIO
Analyst Report: Zoetis Inc.
Apr 30, 2026
•
ZTS
Analyst Report: Regeneron Pharmaceuticals, Inc.
Apr 30, 2026
•
REGN
Analyst Profile
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.
